Description
CJC 1295 no DAC is a GHRH analogue studied in growth hormone release and endocrine-signalling research. Without DAC modification, it is used in models where researchers want to examine shorter-acting GHRH pathway activity.
Molecular Profile
Molecular Weight: Refer to batch COA
Purity: Per batch COA
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water
Research Context
CJC 1295 no DAC is studied in research involving GHRH receptor activation and pulsatile growth hormone signalling. Research teams compare non-DAC and DAC-modified analogues to evaluate peptide duration, receptor signalling, and downstream endocrine response models.
Quality Assurance
Each batch is independently tested for purity, identity, and quality before release. A Certificate of Analysis is available for every lot. All compounds are produced under strict quality control conditions and shipped under appropriate handling protocols from within Canada.
